Vera Therapeutics, Inc. , a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States.
Vera Therapeutics stock last closed at $7.48, up 4.91% from the previous day, and has decreased 64.92% in one year. It has underperformed other stocks in the Biotechnology industry by 0.41 percentage points. Vera Therapeutics stock is currently +43.85% from its 52-week low of $5.20, and -70.01% from its 52-week high of $24.94.
There are currently 27.66M shares of VERA outstanding. The market capitalization of VERA is $206.88M. In the past 24 hours, 591,964 VERA shares were traded.
How to Buy Vera Therapeutics Stock
Not sure how to invest in Vera Therapeutics stock? Here's how.
Choose where to buy Vera Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you determine where to buy Vera Therapeutics stock.
Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Deposit money your brokerage account: Pick your method of payment and add your information.
Research Vera Therapeutics stock: The Vera Therapeutics ticker symbol is VERA. Is Vera Therapeutics stock a good investment? Should you buy shares of VERA? How do VERA's underlying business fundamentals look? Do top analysts think Vera Therapeutics is a good buy? Why has VERA's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if VERA is a good stock to buy).
Make your VERA buy order: Decide if you will purchase VERA shares at the current market price or use a limit order to buy VERA stock at a given price.
Get notifications regarding your VERA investment: Create a watchlist to watch your investment in Vera Therapeutics shares.
Step 1: Choose where to buy Vera Therapeutics stock
You need an online brokerage account in order to access the NASDAQ market and buy VERA shares.
A brokerage account is an investment account that enables you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
Invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to world markets: From Tech to Utilities, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro now.
Once you have chosen the best place to buy Vera Therapeutics stock, it's absolutely critical to evaluate their stock prior to buying, so you can wrap your head around the risk and opportunity.
Overview of key VERA info
VERA Price
$7.48
1w %
1.63%
1y %
-64.92%
5y %
N/A
P/E
-2.38x
P/B
1.96x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$73.46M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$206.88M
Next Earnings
Mar 23, 2023
Next Dividend
N/A
Vera Therapeutics Overview
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis in minutes instead of hours.
There are more short-term assets than long-term liabilities on the VERA balance sheet.
VERA has cash burn of 52934000. It has sufficient cash and short-term investments to cover this for at least one year.
VERA has $114.42M in cash and short term investments. This is sufficient to cover its annual cash burn of $52.93M.
VERA has a low debt to equity ratio of 0.24.
There are more short-term assets than short-term liabilities on the VERA balance sheet.
Is it a good time to buy Vera Therapeutics stock, according to Wall Street analysts?
Out of 4 sell side analysts who research VERA, the consensus analyst rating on Vera Therapeutics is a Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
Latest VERA Analyst Upgrades/Downgrades
Maury Raycroft, a bottom 14% analyst from Jefferies downgrades VERA to a hold rating and lowers their VERA price target from $32.00 to $6.00, on Jan 4, 2023.
Laura Chico, a bottom 6% analyst from Wedbush downgrades VERA to a hold rating and announces their VERA price target of $8.00, on Jan 4, 2023.
Ed Arce, a top 8% analyst from HC Wainwright & Co. maintains VERA with a buy rating and lowers their VERA price target from $36.00 to $15.00, on Jan 4, 2023.
Anupam Rama, a bottom 2% analyst from JP Morgan maintains VERA with a strong buy rating and raises their VERA price target from $35.00 to $38.00, on Nov 18, 2022.
No, Vera Therapeutics doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your VERA buy order
You have two primary types of orders:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are mostly the best for newer investors.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at a given dollar amount, place a limit order.
Click the Open button and eToro will execute your order.
If you want more info about investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Vera Therapeutics share?
As of Mar 20, 2023, it costs $7.48 to buy one share of Vera Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.401 shares of VERA.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.